NCT07229053

Brief Summary

The stage at which functional recovery stops during the rehabilitation programme and which is one of the important determinants of the discharge decision is called "plateau". Although the definition of plateau is not clear, it is assessed with scales valid for a specific patient. Generally, plateau is not a stage in which functional recovery is completely terminated in stroke patients, but a period of pause. Detection of the plateau stage is important in planning the interruption of treatment and discharge of patients who continue inpatient rehabilitation programme. Factors causing plateau should be identified and necessary modifications should be made for effective continuation of the rehabilitation programme.The average length of hospital stay (weeks) of patients hospitalised due to hemiplegia since the opening of Etlik City Hospital will be determined. Patients will be divided into two groups as those hospitalised for shorter and longer than the average length of stay.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
134

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 14, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

February 24, 2026

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

July 7, 2025

Last Update Submit

February 22, 2026

Conditions

Keywords

stroke rehabilitationhospitalisationinpatient rehabilitation duration

Outcome Measures

Primary Outcomes (1)

  • Functional Independence Scale

    first day of inpatient rehabilitation, before discharged from hospital

Secondary Outcomes (4)

  • Berg Scale

    first day of inpatient rehabilitation, before discharged from hospital

  • Mini Mental State Test

    first day of inpatient rehabilitation

  • Beck Depression Scale

    first day of inpatient rehabilitation

  • Beck depression scale

    first day of inpatient rehabilitation

Study Arms (2)

patients who stay hospital shorter than mean duration

The average length of hospital stay (weeks) of patients hospitalised due to hemiplegia since the opening of Etlik City Hospital will be determined. Patients will be divided into two groups as those hospitalised for shorter and longer than the average length of stay.

patients who stay hospital longer than mean duration

The average length of hospital stay (weeks) of patients hospitalised due to hemiplegia since the opening of Etlik City Hospital will be determined. Patients will be divided into two groups as those hospitalised for shorter and longer than the average length of stay.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who approved for inpatient stroke rehabilitation

You may qualify if:

  • Followed by ischaemic or haemorrhagic stroke
  • No more than 2 years have passed since the date of the incident
  • Patients and their carers who are over 18 years of age

You may not qualify if:

  • Cognitive or psychological impairment of the patient or carer
  • The patient is discharged voluntarily or transferred to another department without completing the treatment
  • Not volunteering to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Ayşe Naz Kalem Özgen, specialist

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PM&R Specialist

Study Record Dates

First Submitted

July 7, 2025

First Posted

November 14, 2025

Study Start

September 1, 2025

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

February 24, 2026

Record last verified: 2025-06

Locations